Novel Psychoactive Substances: A New Challenge for Prevention and Treatment

Máté Kapitány-Fövény; Ornella Corazza; Shanna Marrinan; Zsolt Demetrovics

doi:10.1017/9781108632591.032

Novel Psychoactive Substances: A New Challenge for Prevention and Treatment

Máté Kapitány-Fövény, Ornella Corazza, Shanna Marrinan, Zsolt Demetrovics

University of Hertfordshire

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

In the past two decades, the emergence of Novel Psychoactive Substances (NPS) has changed the face of drug markets. Synthetic cathinones, synthetic cannabinoid receptor agonists, novel synthetic opioids, tryptamines, and piperazines became popular alternatives to illicit drugs, primarily because of their easy availability, low price, and intense effects. Analogous NPS are also often misold as traditional drugs due to the often broader profit margins and lower criminal risk profile associated with them. This chapter aims to provide an overview of the epidemiology, user and consumption characteristics, toxicity, and pharmacokinetics of the most proliferate NPS, alongside an introduction to effective prevention and treatment methods for both adolescent and adult populations of NPS users.

Original language	English
Title of host publication	The Cambridge Handbook of Substance and Behavioral Addictions
Publisher	Cambridge University Press India
Pages	307-325
Number of pages	19
ISBN (Electronic)	9781108632591
ISBN (Print)	9781108427166
DOIs	https://doi.org/10.1017/9781108632591.032
Publication status	Published - 1 Jan 2020

Keywords

Cathinones
NPSs
Opioids
Piperazines
Prevention
SCRAs
Synthetic drugs
Treatment
Tryptamines

Access to Document

10.1017/9781108632591.032

Cite this

@inbook{bbf0d6cf1ec549f681ec2096b2b430f7,

title = "Novel Psychoactive Substances: A New Challenge for Prevention and Treatment",

abstract = "In the past two decades, the emergence of Novel Psychoactive Substances (NPS) has changed the face of drug markets. Synthetic cathinones, synthetic cannabinoid receptor agonists, novel synthetic opioids, tryptamines, and piperazines became popular alternatives to illicit drugs, primarily because of their easy availability, low price, and intense effects. Analogous NPS are also often misold as traditional drugs due to the often broader profit margins and lower criminal risk profile associated with them. This chapter aims to provide an overview of the epidemiology, user and consumption characteristics, toxicity, and pharmacokinetics of the most proliferate NPS, alongside an introduction to effective prevention and treatment methods for both adolescent and adult populations of NPS users.",

keywords = "Cathinones, NPSs, Opioids, Piperazines, Prevention, SCRAs, Synthetic drugs, Treatment, Tryptamines",

author = "M{\'a}t{\'e} Kapit{\'a}ny-F{\"o}v{\'e}ny and Ornella Corazza and Shanna Marrinan and Zsolt Demetrovics",

note = "Publisher Copyright: {\textcopyright} Cambridge University Press 2020.",

year = "2020",

month = jan,

day = "1",

doi = "10.1017/9781108632591.032",

language = "English",

isbn = "9781108427166",

pages = "307--325",

booktitle = "The Cambridge Handbook of Substance and Behavioral Addictions",

publisher = "Cambridge University Press India",

}

TY - CHAP

T1 - Novel Psychoactive Substances

T2 - A New Challenge for Prevention and Treatment

AU - Kapitány-Fövény, Máté

AU - Corazza, Ornella

AU - Marrinan, Shanna

AU - Demetrovics, Zsolt

N1 - Publisher Copyright: © Cambridge University Press 2020.

PY - 2020/1/1

Y1 - 2020/1/1

N2 - In the past two decades, the emergence of Novel Psychoactive Substances (NPS) has changed the face of drug markets. Synthetic cathinones, synthetic cannabinoid receptor agonists, novel synthetic opioids, tryptamines, and piperazines became popular alternatives to illicit drugs, primarily because of their easy availability, low price, and intense effects. Analogous NPS are also often misold as traditional drugs due to the often broader profit margins and lower criminal risk profile associated with them. This chapter aims to provide an overview of the epidemiology, user and consumption characteristics, toxicity, and pharmacokinetics of the most proliferate NPS, alongside an introduction to effective prevention and treatment methods for both adolescent and adult populations of NPS users.

AB - In the past two decades, the emergence of Novel Psychoactive Substances (NPS) has changed the face of drug markets. Synthetic cathinones, synthetic cannabinoid receptor agonists, novel synthetic opioids, tryptamines, and piperazines became popular alternatives to illicit drugs, primarily because of their easy availability, low price, and intense effects. Analogous NPS are also often misold as traditional drugs due to the often broader profit margins and lower criminal risk profile associated with them. This chapter aims to provide an overview of the epidemiology, user and consumption characteristics, toxicity, and pharmacokinetics of the most proliferate NPS, alongside an introduction to effective prevention and treatment methods for both adolescent and adult populations of NPS users.

KW - Cathinones

KW - NPSs

KW - Opioids

KW - Piperazines

KW - Prevention

KW - SCRAs

KW - Synthetic drugs

KW - Treatment

KW - Tryptamines

UR - https://www.scopus.com/pages/publications/85192340558

U2 - 10.1017/9781108632591.032

DO - 10.1017/9781108632591.032

M3 - Chapter

AN - SCOPUS:85192340558

SN - 9781108427166

SP - 307

EP - 325

BT - The Cambridge Handbook of Substance and Behavioral Addictions

PB - Cambridge University Press India

ER -

Novel Psychoactive Substances: A New Challenge for Prevention and Treatment

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this